BioCentury
ARTICLE | Company News

ExonHit Therapeutics SA other research news

July 6, 1998 7:00 AM UTC

ExonHit, a gene profiling company, will receive FF5 million (US$830,000) from the French government's ANVAR innovation agency to expand its R&D program for its DATAS (differential analysis of transcri...